Related Experiment Videos

Activities of ciprofloxacin and sparfloxacin against Streptococcus pneumoniae

¹Bayer AG, Pharma Research Centre, Institute for Chemotherapy, Wuppertal, Germany.

|January 1, 1995

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Explorative Randomized Phase II Clinical Study of the Efficacy and Safety of Finafloxacin versus Ciprofloxacin for Treatment of Complicated Urinary Tract Infections.

Antimicrobial agents and chemotherapy·2018

Pharmacodynamics of Finafloxacin, Ciprofloxacin, and Levofloxacin in Serum and Urine against TEM- and SHV-Type Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae Isolates from Patients with Urinary Tract Infections.

Antimicrobial agents and chemotherapy·2017

Analysis of effects of MCB3681, the antibacterially active substance of prodrug MCB3837, on human resident microflora as proof of principle.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2015

Antiviral, antifungal, and antiparasitic activities of fluoroquinolones optimized for treatment of bacterial infections: a puzzling paradox or a logical consequence of their mode of action?

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2014

Resistance surveillance studies: a multifaceted problem--the fluoroquinolone example.

Infection·2012

A long journey from minimum inhibitory concentration testing to clinically predictive breakpoints: deterministic and probabilistic approaches in deriving breakpoints.

Infection·2009

See all related articles